- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Orthopediatrics Corp (KIDS)
The Orthopediatrics share price today is 31.41, view NASDAQ KIDS stock exchange data. Track the latest Orthopediatrics share price with real-time updates on KIDS stock performance including market cap, day range, 52-week range and dividend yield. Access KIDS charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.46
31.80
52 wk Range
14.42
32.62
KIDS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.4631.80
52 wk Range
14.4232.62
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KIDS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
30.75
Downside
-2.10%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
OrthoPediatrics receives Investment Bank Analyst Rating Update- Investing.com
Pro
OrthoPediatrics receives Investment Bank Analyst Rating Update- Investing.com
Pro
- OrthoPediatrics receives Investment Bank Analyst Rating Update
- Investing.com
Pro - OrthoPediatrics receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 30.75
(-2.10% Downside)
Orthopediatrics Corp SWOT Analysis
Pediatric Orthopedics | OrthoPediatrics Corp. dominates the niche pediatric orthopedic market, leveraging specialized focus to drive impressive growth and expand market presence |
Financial Momentum | Explore OrthoPediatrics' robust financial performance, with Q3 2024 revenue surpassing estimates and full-year guidance raised to $202-$204 million |
Strategic Expansion | Delve into the company's ambitious clinic network expansion plans, aiming to open 18 new markets by 2027 and strengthen its market position |
Future Projections | Analysts project revenue to reach $242-$244 million by 2025, with improving profitability and a target price of $50 set by JMP Securities |
Orthopediatrics Corp Earnings Call Summary for Q3/2026
- OrthoPediatrics reported record Q3 revenue of $72.7M, up 19% YoY, beating estimates of $68.49M; adjusted EPS of -$0.23 matched forecasts.
- Company raised FY2026 revenue guidance to $270M-$273M, implying 14-16% growth, while reiterating adjusted EBITDA guidance of approximately $25M.
- Gross margin held steady at 74%; adjusted EBITDA rose to $6.9M from $6.2M YoY, with free cash flow turning positive at $1.6M versus -$3.4M prior year.
- New product launches including 3P Hip, TRAXIO, and VerteGlide gaining traction; 3P Small/Mini expected H1 2027, with eLLi positioned for 2028-2029.
- Shares jumped 6.63% after-hours to $25.40 on revenue beat and raised outlook; specialty bracing grew 20%+ with clinic expansion exceeding 60 locations.
Last Updated: 28-10-2026, 03:22 am
Read Full TranscriptEarnings
Latest Release
27-10-2026
EPS / Forecast
-0.23 / -0.23
Revenue / Forecast
72.7M / 68.49M
Compare KIDS to Peers and Sector
Metrics to compare | KIDS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKIDSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −23.8x | 15.6x | −0.2x | |
PEG Ratio | −0.86 | 0.10 | 0.00 | |
Price/Book | 2.4x | 2.2x | 2.6x | |
Price / LTM Sales | 3.1x | 1.9x | 2.8x | |
Upside (Analyst Target) | −2.1% | 60.8% | 65.5% | |
Fair Value Upside | Unlock | 29.0% | 8.9% | Unlock |
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Orthopediatrics (KIDS) Share Price Today?
The Orthopediatrics share price today is 31.41.
What is the current Orthopediatrics (KIDS) share price and day range?
As of 03-11-2026, the Orthopediatrics share price is 31.41, with a previous close of 30.43. The share price has ranged from 30.46 to 31.80 today, while the 52-week range spans from 14.42 to 32.62.
What Is the Orthopediatrics Market Cap?
As of today, Orthopediatrics market cap is 813.34M.
What Is the Orthopediatrics (KIDS) Share Price Target?
The average 12-month share price target for Orthopediatrics is 30.75, with a high estimate of 38 and a low estimate of 27. 6 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and -2.10% Downside potential.
What Is Orthopediatrics's Earnings Per Share (TTM)?
The Orthopediatrics EPS (TTM) is -1.42.
When Is the Next Orthopediatrics Earnings Date?
Orthopediatrics will release its next earnings report on 10-03-2027.
From a Technical Analysis Perspective, Is KIDS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Orthopediatrics Trade On?
Orthopediatrics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Orthopediatrics?
The stock symbol for Orthopediatrics is "KIDS."
How Many Times Has Orthopediatrics Stock Split?
Orthopediatrics has split 0 times.
How Many Employees Does Orthopediatrics Have?
Orthopediatrics has 602 employees.
What Is the KIDS After Hours Price?
KIDS's last after hours stock price is 30.94, the stock has changed by -0.47, or -1.50%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.